Form 4 Filing for Ardent Health, Inc. - Officer Stock Transaction

This SEC Form 4 filing reports a transaction by Dave Caspers, CEO and President of Ardent Health, Inc. On July 1, 2026, Caspers acquired 103,653 shares of Common Stock through restricted stock units. These units vest in three equal installments annually starting July 1, 2026, contingent upon continued service. The reported acquisition had a transaction price of $0.00 per share. Following this transaction, Caspers holds a total of 174,930 shares of Common Stock. The filing was signed by Stephen C. Petrovich as Attorney-in-Fact on July 2, 2026.